Gene Editing Breakthrough
Alan and Danny discuss the potential of gene editing through CRISPR technology to target the PCSK nine gene, leading to increased expression of the LDL receptor for more efficient cholesterol clearance. This innovative approach could revolutionize the treatment of atherosclerotic cardiovascular disease, paving the way for a new era in healthcare.In this clip
From this podcast
The Proof with Simon Hill
Cholesterol, metabolic health and heart disease | Dr Alan Flanagan and Danny Lennon
Related Questions
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?
How do PCSK9 inhibitors reduce apoB in the context of the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol Breakthroughs?
Should I use statins or PCSK9 inhibitors to lower LDL and apoB as discussed in the episode Dr. Peter Attia on Longevity Drugs, Alzheimer's Disease, and The 3 Most Important Levers to Pull and the clip Cholesterol and Health?